Device Trial Radar · NCT07720557
PulseMagic™ TrueForce™ PAF NMPA Study
Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jul 10, 2026
Primary completion
Jul 1, 2028
Study completion Nov 30, 2028
Sponsor
- Lead sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).
Conditions
- Atrial Fibrillation (AF)
- Paroxysmal AF
- Drug Refractory Paroxysmal Atrial Fibrillation
- Atrial Arrhythmia
Interventions
PFA Ablation catheterDevice
Deliver PF energy using the PulseMagic™ PFA system
Primary outcomes
What the sponsor says the trial is designed to measure.
- The success rate within 12 months after operation treatment without AADsTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.